Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-20-013521
Filing Date
2020-06-10
Accepted
2020-06-10 16:32:15
Documents
3
Effectiveness Date
2020-06-10

Document Format Files

Seq Description Document Type Size
1 S-8 forms8.htm S-8 62745
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 6100
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 2446
  Complete submission text file 0001140361-20-013521.txt   72327
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239077 | Film No.: 20955026
SIC: 2836 Biological Products, (No Diagnostic Substances)